Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elisa Garcia Garre"'
Autor:
Gines Luengo-Gil, Enrique Gonzalez-Billalabeitia, Sergio Alejo Perez-Henarejos, Esther Navarro Manzano, Asuncion Chaves-Benito, Elena Garcia-Martinez, Elisa Garcia-Garre, Vicente Vicente, Francisco Ayala de la Peña
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194638 (2018)
BACKGROUND:Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its relevance for clinical resistance to antiangiogenic drugs is still incompletely understood. Recen
Externí odkaz:
https://doaj.org/article/dd106c7a60b943b68c3fd6b0448f99f6
Autor:
Carlos E. Robles, Amparo Oltra, Raquel Bratos, Fernando Salvador Moreno, Isabel Gallegos, Iñaki Álvarez-Busto, Manuel Ruiz-Borrego, Salvador Blanch, Marta Santisteban, Elisa Garcia-Garre, José E. Alés-Martínez, Diego Malón, Maria Gonzalez-Cao, Cristina Reboredo, Maria Jose Echarri, Serafin Morales, Juan I. Delgado-Mingorance, Ana Isabel Ballesteros, César A. Rodríguez, Blanca Hernando, Miguel Angel Cabrera, Mafalda Oliveira, Cristina Hernando, Raquel Andrés, Isabel Echeverría, Lucía González-Cortijo, Elena Aguirre, Marta Legeren, Rafael López, Antonio Llombart-Cussac, Estela Vega, Elena Galve, Luis Manso, Sonia Servitja, María Galán
Publikováno v:
Scientia
The Breast : Official Journal of the European Society of Mastology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Breast (Edinburgh, Scotland)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BREAST
r-FISABIO. Repositorio Institucional de Producción Científica
Breast, Vol 54, Iss, Pp 286-292 (2020)
The Breast : Official Journal of the European Society of Mastology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Breast (Edinburgh, Scotland)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BREAST
r-FISABIO. Repositorio Institucional de Producción Científica
Breast, Vol 54, Iss, Pp 286-292 (2020)
Background: This study evaluated efficacy and safety of palbociclib, a CDK4/6 inhibitor, in heavilypretreated hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/ HER2(-)) metastatic breast cancer (mBC) patients durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3c7a63a16cdef7943832a5179a8480
https://hdl.handle.net/11351/6372
https://hdl.handle.net/11351/6372
Autor:
T. Bachelot, E. Ciruelos, A. Schneeweiss, F. Puglisi, T. Peretz-Yablonski, I. Bondarenko, S. Paluch-Shimon, A. Wardley, J.-L. Merot, Y. du Toit, V. Easton, N. Lindegger, D. Miles, Kamel Bouzid, Mario Campone, Bruno Coudert, Zbigniew Nowecki, Hassan Errihani, Florence Dalenc, Ana Ferreira, Max Mano, Francesco Ricci, Haralabos Kalofonos, Claudia Andreetta, Filippo Montemurro, Sophie Barrett, Qingyuan Zhang, Dimitris Mavroudis, Juan Matus, Carlos Beato, Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, Istvan Lang, Sunil Verma, Huiping Li, Etienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael Lux, Antonio Frassoldati, Zeba Aziz, Fernando Salas, Joanna Streb, Andrzej Wronski, Salomón Menjón Beltrán, Irfan Cicin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boer, Balazs Juhasz, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Snezana Susnjar, Erika Matos, Ruchan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomón Stemmer, Flavia Morales Vásquez, Adriana Dominguez, Marek Wojtukiewicz, Jasna Trifunovic, Jose Juan Illarramendi, Laura Garcia, Yann Izarzugaza Peron, Maria Jose Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard De Boer, Guy Jerusalem, Véronique Cocquyt, Carlos Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, Michel Gozy, Georgios Vasilopoulos, Janos Revesz, Luciano Latini, Cesare Gridelli, Jesus Lazaro, Antonio Gonzalez, Agusti Barnadas Molins, Eduardo Martinez, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard Baird, Belinda Yeo, Nicole McCarthy, Richard Greil, Shusen Wang, Xavier Artignan, Paule Augereau, Ingolf Juhasz-Boess, Roger Ngan, Hadassah Goldberg, Francesco Di Costanzo, Francesco Ferraù, Eduardas Aleknavicius, Kamran Rashid, Luís Costa, Jose Angel Garcia, Luis Ruiz de la Cruz, Rafael López López, Olga Del Val, Ozgur Ozyilkan, Fathi Azribi, Mark Verrill, Nicholas Turner, Jane Beith, Andreas Petzer, Jurandyr Andrade, Vanessa Bernstein, Daniel Rayson, Ibtessam Saad Eldin, Mihaëla Achille, Volkmar Mueller, Alessandra Gennari, Stefano Cascinu, Marwan Ghosn, Nagi El-Saghir, Joan Van den Bosch, Rianne Oosterkamp, Monika Kukulska, Ignacio Pelaez, Carolina Hernandez, Maria del Mar Gordon, Elsa Dalmau, Jose Luis Alonso, Sercan Aksoy, Hasan Senol Coskun, Yaroslav Shparyk, Mohini Varughese, Udaiveer Panwar, Lisa Barraclough, Nicola Levitt, Jonathan Hicks, Anna Rigg, Mark Allen, Cecila Castillo, Luis Enrique Fein, Robin Stuart-Harris, Christian Singer, Herbert Stoeger, Sasha Smiljanic, Jifeng Feng, Miguel Cedeño, Jean Francois Berdah, Hubert Orfeuvre, Anthony Goncalves, Eva-Maria Grischke, Eike Simon, Steffen Wagner, Anna Efremidou, Konstantinos Papazisis, Ella Evron, Moshe Inbar, Noa Ben Baruch, David Geffen, Natalya Karminsky, Enzo Maria Ruggeri, Cavanna Luigi, Donatella Grasso, Elona Juozaityte, Jeronimo Rafael Rodriguez Cid, Henk Roerdink, Neelum Siddiqi, José Luís Passos Coelho, Elisa Garcia Garre, Andres Garcia, Noelia Martínez Jañez, Maria Helena Lopez Ceballos, Mireia Mele, María García, Alberto Arcediano, Karen McAdam, Timothy Perren, Wendy Taylor, Alison Humphreys, Raul Vera, Luis Alberto Kaen, Günther Steger, Johannes Andel, Jacques de Grève, Manon Huizing, Roberto Hegg, Anil Joy, Sandeep Sehdev, Riina Kütner, Johanna Ruohola, Nadine Dohollou, Jessica Grosjean, Philippe Laplaige, Rémy Largillier, Philippe Martin, Virginie Pottier, Jerome Alexandre, Bernd Christensen, Dirk-Michael Zahm, Fariba Khandan, Hans-Joachim Lueck, Georgios Fountzilas, Georgeta Fried, Alice Giacobino, Andrea Bonetti, Yanin Chavarri Guerra, Laurens Van Warmerdam, Annette Van der Velden, Suzan Vrijaldenhoven, Felix de Jongh, Milagros Cavero, Raquel Andres Conejero, Adolfo Murias, Salvador Saura, Amparo Oltra, Andres Redondo, Nuria Ribelles, Kilian Bachmeier, Johnathan Joffe, Prabir Chakraborti, Mark Beresford, Mohammad Butt, Christopher Poole, Gassan Yordi, Natasha Woodward, Gilberto Amorim, Nadia Califaretti, Susan Fox, Andre Robidoux, NanLi Li, Nenxiao Li, Jun Jiang, Tannia Soria, Peeter Padrik, Outi Saarni, Dominique Genet, Stéphanie Catala, Hugues Barletta, Luis Teixeira, Thomas Facchini, Tobias Hesse, Thorsten Kühn, Angelika Ober, Roland Repp, Willibald Schroeder, Dimitrios Pectasides, Gyorgy Bodoky, Zsuzsanna Kahan, Irina Jiveliouk, Ora Rosengarten, Oscar Alabiso, Mario Perez, Yes Van de Wouw, Jolanta Smok-Kalwat, Margarida Damasceno, Gabriela Sousa, Omalkhair Abulkhair, Antonio Antón Torres, Maria Purificación Martinez, Jesús Garcia Mata, Marta Santisteban Jesús Florián Jerico, Antonio Llombart, Rosa Sanchez, Juan Carlos Torrego, Clara Olier Garate, Cesar Rodriguez, Rosa Llorente, Diego Soto de Prado, Javier Cortés, Cristina Llorca, Antonio Galán, Gemma Viñas Villaro, Ulrik Narbe, Helena Granstam Bjömeklett, Sarah Westwell, Jackie Newby, Mariam Jafri, Robinson Rodríguez, Isabel Alonso
Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on results from the phase III CLEOPATRA trial. PERUSE was designed to assess the safety and efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7394dbd3f670d60bcbd805c7b372138
https://hdl.handle.net/20.500.14017/e2dbbab9-c685-4110-8d14-e0e540d6de6b
https://hdl.handle.net/20.500.14017/e2dbbab9-c685-4110-8d14-e0e540d6de6b
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
Autor:
Ginés Luengo-Gil, Elisa Garcia-Garre, Enrique Gonzalez-Billalabeitia, Elena García-Martínez, Vicente Vicente, Esther Navarro-Manzano, Pablo Conesa-Zamora, Asunción Chaves-Benito, Francisco Ayala de la Peña, Alberto Martínez-Carrasco
Publikováno v:
Cellular oncology (Dordrecht). 42(5)
The analysis of breast cancer residual tumors after neoadjuvant chemotherapy (nCT) may be useful for identifying new biomarkers. MicroRNAs are known to be involved in oncogenic pathways and treatment resistance of breast cancer. Our aim was to determ
Autor:
José Aguilar Jiménez, Alejandra Ivars Rubio, María Martínez Gálvez, Francisco Ayala, Elisa Garcia-Garre, Gema Marin Zafra, Pilar de la Morena, Elena Garcia Martinez, Marina Garcia Gomez, Esmeralda Garcia Torralba, Esther Navarro Manzano
Publikováno v:
Journal of Clinical Oncology. 38:e12524-e12524
e12524 Background: Nodal micrometastatic disease (ypN1mic) after neoadjuvant chemotherapy (nCT) for breast cancer (BC) is considered an indication for axillary lymph node disection. While pN1mic prognostic impact has been extensively studied, the pro
Autor:
Jose Ignacio Chacon, Miguel Gil, Elisa Garcia-Garre, Isabel Garau Llinas, Guillermo Lopez-Vivanco, Luis Manso, Manuel Ramos Vazquez, Andrés Redondo, César A. Rodríguez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background: Randomized controlled trials of the first-line combination of bevacizumab and chemotherapy in patients with metastatic breast cancer (MBC) have shown improvements in tumor response and progression-free survival (PFS). Objective: The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ac9cea45a60f68be5e33b3b5ae618d
https://doi.org/10.2147/ott.s170303
https://doi.org/10.2147/ott.s170303
Autor:
Asunción Chaves-Benito, Ginés Luengo-Gil, Francisco Ayala de la Peña, Enrique Gonzalez-Billalabeitia, Elisa Garcia-Garre, Vicente Vicente, Elena García-Martínez, Esther Navarro Manzano, Sergio Alejo Perez-Henarejos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 4, p e0194638 (2018)
PLoS ONE, Vol 13, Iss 4, p e0194638 (2018)
Background Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its relevance for clinical resistance to antiangiogenic drugs is still incompletely understood. Recen
Autor:
Emilia García-Martínez, Elisa Garcia-Garre, F. Ayala de la Peña, A Fernández Sánchez, M.A. Ivars, J.C. Yufera Soler, E. Navarro Manzano, P de la Morena Barrio, R. Salguero Aguilar, Tsai García, G. Marin Zafra
Publikováno v:
Annals of Oncology. 28:v94
Autor:
Susana Roselló, Paloma Martín-Martorell, Begoña Bermejo, Elisa Garcia-Garre, Esther Jordá, Isabel Chirivella, Cecilia Guzman, Jose Alejandro Perez-Fidalgo, Ana Lluch
Publikováno v:
Breast Cancer Research and Treatment. 120:245-251
Adjuvant chemotherapy prolongs survival in patients with breast cancer, but it also causes side effects such as ovarian-function suppression. The incidence of chemotherapy-induced amenorrhea (CIA) varies depending on the patients' age, dose and the t
Autor:
Ramon Perez-Carrion, Guillermo Lopez-Vivanco, Manuel Ramos Vazquez, César A. Rodríguez, I Garau, Elisa Garcia-Garre, Andrés Redondo, Luis Manso, Miquel Gil, Jose Ignacio Chacon
Publikováno v:
Journal of Clinical Oncology. 35:e12563-e12563
e12563 Background: Randomized controlled trials in MBC patients evaluating bevacizumab as first-line treatment showed improvements in tumor response and progression-free survival (PFS) when added to chemotherapy. The aim of the LORENA study was to de